Internship

PhD Internship: Applied Machine Learning Genomics

Posted on 11/26/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Cambridge, MA, USA

Category
Applied Machine Learning
AI & Machine Learning
Required Skills
Python
R
Linux/Unix
Requirements
  • PhD student in Computational Biology, Computer Science, Bioinformatics, Biostatistics, or related fields.
  • Experience using Python to analyze genomics data.
  • Experience working in high-performance computing (HPC) and Linux environments.
  • Experience with imaging data analysis is preferred but not required.
  • Knowledge of R would be a plus but not required.
Responsibilities
  • Explore and evaluate a published spatial trajectory analysis method.
  • Apply the selected method to a well-characterized ST dataset and interpret disease state changes, with support from other colleagues.
  • If time allows, benchmark the method against baseline models and other published methods.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's licensing agreement with Prime Medicine boosts its cell and gene therapy pipeline.
  • The focus on personalized medicine enhances BMS's position in precision oncology.
  • BMS's commitment to ESG initiatives aligns with industry sustainability trends.

What critics are saying

  • BMS faces potential financial liabilities from the refiled $6.4 billion UMB lawsuit.
  • The lawsuit against HRSA and HHS could lead to regulatory challenges.
  • High R&D costs and risks are associated with the AI Proteins collaboration.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb focuses on innovative medicines in oncology, immunology, and cardiovascular areas.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE